Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-aminopyridine for Cognitive and Motor Function in MS
NCT02280096Phase 2Completed
- Sponsor
- Coordinación de Investigación en Salud
- Start
- Oct 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalfampridine in multiple sclerosis (MS), sponsored by Coordinación de Investigación en Salud. Started Oct 2014; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02280096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280096.